Analyst Ratings for Avidity Biosciences (RNA)
RNA Rating Summary
RNA Price Target Summary
- Highest: $60.00 (Cantor Fitzgerald)
- Lowest: $18.00 (Leerink Partners)
- Average: $39.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.00 (+55.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$39.00 (+55.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2024 | Cantor Fitzgerald | Eric Schmidt | New Coverage | Overweight (N/A) |
60.00 (N/A) |
24.83 (25.09) |
1.05% | Details |
| 5/22/2023 | Evercore ISI | Josh Schimmer | Upgrade | Outperform (In Line) |
N/A (N/A) |
10.82 (25.09) |
131.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
